Explore 3 Stock Ideas & Industry Insights Download Free Report

Company price
11.42 USD -0.45 ( 3.79%)
Last update at 2026-11-20T21:00:00Z
VOLUME
1014326
Market Cap
642.43M
P/E
57.50

Momentum Score

…

Phreesia, Inc. provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. It offers solutions including appointment optimization and referral management using AI-enabled workflows; and AI-based smart answering solution patient communications supported by voice and messaging solutions; integrated payment solutions embedded in intake and post-visit workflows, and financing solutions that enable healthcare organizations to accelerate cash collections while offering flexible payment options to patients; and digital intake and clinical data capture, patient engagement and activation tools, and measurement and analytics solutions. It also offers PhreesiaPads, a self-service intake tablets; and Arrivals Kiosks, which are on-site kiosks. The company serves a range of healthcare organizations including ambulatory practices, health systems, and hospitals, as well as life sciences companies, government entities, patient advocacy, public interest and not-for-profit and other organizations. Phreesia, Inc. was incorporated in 2005 and is based in Wilmington, Delaware.

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Day Price Range
11.34
Low
12.16
High
52 Week Price Range
7.77
Low
25.00
High

Momentum Score

…
Loading momentum score…

A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.

Score - Rating
>= 1 - Low / > 1 but < 2 - Below Average / > 2 but < 3 - Average / > 3 but < 4 - Above Average / > 4 - High
AI Summary

Phreesia provides patient intake and revenue-cycle management software that automates check-in, insurance capture, payments and related workflows for ambulatory and outpatient providers. Long-term growth may be driven by ongoing healthcare digitization, expansion of payment and RCM services, and deeper integration with electronic health record systems. Investors may find the recurring SaaS model, an established provider customer base and data-enabled operational efficiencies attractive.
The company faces material risks from competition with EHR vendors and other digital-health firms, sensitivity to provider spending and reimbursement trends, and operational and data-security exposure related to handling protected health information.

Risk Score
Medium

Note: The summary and risk score provided above is created by AI and should not be construed as a recommendation of Kalkine.

Key Metrics*

Previous Close
11.87
Dividend Yield
-
Revenue TTM
507.79M
Revenue Per Share
8.35
Gross Profit TTM
342.86M
Debt / Equity
0.30
ROE
3.12%
Net Debt
28.62M
ROCE
-0.41%
Diluted EPS TTM
0.18

Key Financials*

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2026-01-31 2025-01-31 2024-01-31 2023-01-31 2022-01-31
Type yearly yearly yearly yearly yearly
Date 2026-01-31 2025-01-31 2024-01-31 2023-01-31 2022-01-31
Income before tax -8.94M -55.81M -135.34M -175.66M -117.98M
Net income 2.31M -58.53M -136.88M -176.15M -118.16M
Selling general administrative 79.90M 76.60M 79.93M 80.38M 68.67M
Selling and marketing expenses 100.24M 121.13M 147.01M 151.26M 106.42M
Gross profit 326.47M 284.88M 232.29M 171.64M 131.84M
Reconciled depreciation 31.45M 27.89M 29.49M 25.30M 21.30M
Ebit -1.99M -53.46M -133.49M -176.55M -116.82M
Ebitda 29.47M -25.58M -102.94M -151.25M -95.52M
Depreciation and amortization 31.45M 27.89M 30.54M 25.30M 21.30M
Non operating income net other - - - -0.17M -
Operating income -6.61M -58.10M -136.48M -176.55M -116.82M
Other operating expenses 487.20M 477.91M 492.78M 457.46M 330.05M
Interest expense 6.95M 2.35M 1.85M 1.41M 1.16M
Tax provision -11.25M 2.72M 1.54M 0.48M 0.18M
Interest income 2.17M 2.68M 4.07M 1.06M 1.08M
Net interest income -4.78M 0.33M 2.21M 1.06M -1.08M
Income tax expense -11.25M 2.72M 1.54M 0.48M 0.18M
Total revenue 480.59M 419.81M 356.30M 280.91M 213.23M
Total operating expenses 333.08M 342.98M 368.77M 348.19M 248.66M
Cost of revenue 154.12M 134.93M 124.01M 109.27M 81.39M
Total other income expense net -2.33M 2.29M 1.14M 0.89M -1.16M
Net income from continuing ops 2.31M -58.53M -136.88M -176.15M -118.16M
Net income applicable to common shares 2.31M -58.53M -136.88M -176.15M -118.16M
Breakdown 2026-01-31 2025-01-31 2024-01-31 2023-01-31 2022-01-31
Type yearly yearly yearly yearly yearly
Date 2026-01-31 2025-01-31 2024-01-31 2023-01-31 2022-01-31
Total assets 663.79M 388.42M 370.33M 370.06M 494.48M
Intangible assets 79.76M 80.91M 77.76M 46.55M 30.41M
Other current assets 51.39M 45.45M 42.53M 33.31M 30.63M
Total liab 326.58M 123.61M 118.88M 82.24M 77.20M
Total stockholder equity 337.21M 264.81M 251.45M 287.82M 417.28M
Deferred long term liab - - - 2.68M 3.75M
Other current liab 113.02M 64.13M 68.03M 44.41M 39.72M
Common stock 0.62M 0.60M 0.58M 0.54M 0.52M
Capital stock 0.62M 0.60M 0.58M 0.54M 0.52M
Retained earnings -799.19M -801.50M -742.97M -606.08M -429.94M
Other liab - - - 0.12M 0.07M
Good will 170.06M 75.84M 75.84M 33.74M 33.62M
Other assets 9.79M 3.25M 0.00M 5.09M 7.11M
Cash 73.83M 84.22M 87.52M 176.68M 313.81M
Cash and equivalents 73.83M 84.22M 87.52M 176.68M 313.81M
Total current liabilities 183.24M 114.02M 110.12M 79.04M 68.43M
Current deferred revenue 49.52M 32.76M 24.11M 17.69M 16.49M
Net debt 28.62M -66.42M -75.54M -167.50M -298.01M
Short term debt 9.22M 9.01M 6.45M 6.11M 7.10M
Short long term debt 2.66M 1.22M 1.10M 5.17M 5.82M
Short long term debt total 102.45M 17.80M 11.98M 9.18M 15.80M
Other stockholder equity 1136.16M 1065.75M 993.84M 893.36M 846.70M
Property plant equipment 22.33M 25.13M 17.17M 22.24M 36.98M
Total current assets 279.84M 203.28M 195.68M 262.44M 386.35M
Net tangible assets - - - 254.08M 353.24M
Net receivables 154.63M 73.62M 64.86M 51.39M 40.26M
Long term debt 90.00M 0.72M 2.05M 2.73M 0.14M
Inventory - - 0.77M 1.06M 1.64M
Accounts payable 11.48M 5.62M 8.48M 10.84M 5.12M
Accumulated other comprehensive income -0.38M -0.05M 0.00M - -
Common stock total equity - - - 0.54M -
Retained earnings total equity - - - -606.08M -
Treasury stock - - - -33.60M -13.96M
Non currrent assets other 55.80M 3.25M 3.87M 5.01M 6.59M
Non current assets total 383.95M 185.13M 174.64M 107.62M 108.13M
Capital lease obligations 9.79M 15.87M 8.84M 1.28M 15.80M
Long term debt total 92.12M 8.15M 5.40M 2.73M 7.42M
Breakdown 2026-01-31 2025-01-31 2024-01-31 2023-01-31 2022-01-31
Type yearly yearly yearly yearly yearly
Date 2026-01-31 2025-01-31 2024-01-31 2023-01-31 2022-01-31
Investments - -24.09M -39.67M -26.20M -65.23M
Change to liabilities - - - 7.49M 6.23M
Total cashflows from investing activities -161.88M -24.09M -39.67M -26.20M -65.23M
Net borrowings 83.17M -7.81M -6.78M -0.61M -5.31M
Total cash from financing activities 72.85M -11.49M -17.11M -20.80M 234.97M
Change to operating activities - - - 1.24M -14.58M
Net income 2.31M -58.53M -136.88M -176.15M -118.16M
Change in cash -10.39M -3.30M -89.16M -137.13M 95.03M
Begin period cash flow 84.22M 87.52M 176.68M 313.81M 218.78M
End period cash flow 73.83M 84.22M 87.52M 176.68M 313.81M
Total cash from operating activities 78.81M 32.38M -32.38M -90.12M -74.71M
Issuance of capital stock - - 0.00M 0.00M 245.81M
Depreciation 31.45M 27.89M 29.49M 25.30M 21.30M
Other cashflows from investing activities -13.30M -15.38M -19.29M -21.47M -34.42M
Dividends paid - - 12.18M - 0.00M
Change to account receivables -10.15M -8.81M -11.21M -11.13M -10.22M
Sale purchase of stock 1.45M 1.01M -12.18M -19.38M -8.99M
Other cashflows from financing activities -14.15M -7.61M 1.84M 2.71M 2.42M
Change to netincome - - - 59.21M 38.22M
Capital expenditures 11.10M 24.09M 25.10M 26.20M 30.80M
Change receivables - - - -11.13M -
Cash flows other operating - - - 4.84M -
Cash and cash equivalents changes - - - -137.13M -
Change in working capital -14.09M -6.49M -1.64M -3.86M -18.57M
Stock based compensation 67.45M 66.97M 71.70M 58.77M 36.14M
Other non cash items 4.96M 2.33M 4.73M 5.37M 4.43M
Free cash flow 67.71M 8.29M -57.48M -116.33M -105.52M

Peer Comparison*

Sector: Healthcare Industry: Health Information Services

Stock Name
Change
(USD)
Price
(USD)
Trailing
PE (x)
Forward
PE (x)
Price Sales
TTM (x)
Price to Book Value (x)
Enterprise Value
to Revenue (x)
Enterprise Value
to EBITDA (x)
PHR
Phreesia Inc
-0.45
3.79%
11.42 57.50 12.80 1.27 1.72 1.25 12.69
VEEV
Veeva Systems Inc Class A
-0.05
0.02%
266.22 43.49 29.59 12.48 5.79 10.39 33.41
PMCUF
Pro Medicus Limited
-6.60
5.03%
124.50 64.90 90.91 49.11 38.05 65.12 83.47
TEM
Tempus AI, Inc. Class A Common Stock
-5.60
9.39%
54.01 - - 8.68 25.39 8.33 -
MTHRY
M3 Inc
-0.07
1.31%
5.28 31.84 26.25 0.05 4.60 0.04 0.12

Profile*

Phreesia Inc

Phreesia, Inc. provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. It offers solutions including appointment optimization and referral management using AI-enabled workflows; and AI-based smart answering solution patient communications supported by voice and messaging solutions; integrated payment solutions embedded in intake and post-visit workflows, and financing solutions that enable healthcare organizations to accelerate cash collections while offering flexible payment options to patients; and digital intake and clinical data capture, patient engagement and activation tools, and measurement and analytics solutions. It also offers PhreesiaPads, a self-service intake tablets; and Arrivals Kiosks, which are on-site kiosks. The company serves a range of healthcare organizations including ambulatory practices, health systems, and hospitals, as well as life sciences companies, government entities, patient advocacy, public interest and not-for-profit and other organizations. Phreesia, Inc. was incorporated in 2005 and is based in Wilmington, Delaware.

1521 Concord Pike, Wilmington, DE, United States, 19803

888 654 7473

1789

Name Title Year Born
Mr. Chaim Indig Co-Founder, CEO & Director 1979
Mr. Evan Roberts Co-Founder & COO 1980
Mr. Randy Rasmussen Chief Financial Officer 1980
Ms. Allison C. Hoffman Gen. Counsel & Sec. 1971
Mr. David Linetsky Sr. VP of Life Sciences 1979
Mr. Daniel Nathan Chief Technology Officer 1977
Mr. Balaji Gandhi Sr. VP of Investor Relations NA
Ms. Maureen McKinney VP of Corp. Communications NA
Ms. Amy Beth VanDuyn Sr. VP of HR 1974
Mr. Michael J. Davidoff Sr. VP of Payer Solutions 1973

Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.

Support

Hi! How can we help you today?

Loading…